ID   KFR
AC   CVCL_S637
DR   Wikidata; Q54899826
RX   PubMed=8180967;
RX   PubMed=12670897;
RX   PubMed=23665679;
RX   PubMed=23882450;
RX   PubMed=25749379;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
RX   PubMed=8180967; DOI=10.1016/0304-3835(94)90029-9;
RA   Cinatl J. Jr., Cinatl J., Hernaiz Driever P., Rabenau H.F., Novak M.,
RA   Benda R., Gumbel H.O., Kornhuber B., Doerr H.-W.;
RT   "Induction of myogenic differentiation in a human rhabdomyosarcoma
RT   cell line by phenylacetate.";
RL   Cancer Lett. 78:41-48(1994).
//
RX   PubMed=12670897;
RA   Cinatl J. Jr., Cinatl J., Michaelis M., Kabickova H., Kotchetkov R.,
RA   Vogel J.-U., Doerr H.-W., Klingebiel T., Hernaiz Driever P.;
RT   "Potent oncolytic activity of multimutated herpes simplex virus G207
RT   in combination with vincristine against human rhabdomyosarcoma.";
RL   Cancer Res. 63:1508-1514(2003).
//
RX   PubMed=23665679; DOI=10.1038/onc.2013.129;
RA   Sokolowski E., Turina C.B., Kikuchi K., Langenau D.M., Keller C.;
RT   "Proof-of-concept rare cancers in drug development: the case for
RT   rhabdomyosarcoma.";
RL   Oncogene 33:1877-1889(2014).
//
RX   PubMed=23882450; DOI=10.3389/fonc.2013.00183;
RA   Hinson A.R.P., Jones R., Crose L.E.S., Belyea B.C., Barr F.G.,
RA   Linardic C.M.;
RT   "Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research:
RT   utility and pitfalls.";
RL   Front. Oncol. 3:183.1-183.12(2013).
//
RX   PubMed=25749379; DOI=10.18632/oncotarget.2889;
RA   Michaelis M., Rothweiler F., Loschmann N., Sharifi M., Ghafourian T.,
RA   Cinatl J. Jr.;
RT   "Enzastaurin inhibits ABCB1-mediated drug efflux independently of
RT   effects on protein kinase C signalling and the cellular p53 status.";
RL   Oncotarget 6:17605-17620(2015).
//